MedTrace Logo

Establishing an Inflammatory Breast Cancer Registry

NCT00340158 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 164

Last updated 2010-04-23

No results posted yet for this study

Summary

Inflammatory breast carcinoma (IBC) is an extremely rare, aggressive form of breast cancer that disproportionately impacts young women. IBC often affects the skin of the breast, as well as the breast itself, making it appear inflamed. The purpose of this study is to collect data and information on IBC patients so that researchers can study factors associated with IBC. The data and information collected will be used to establish the IBC Registry, a private cancer registry.

Approximately 300 persons who are 18 years or older and who have been diagnosed with IBC will participate in this study. Participants will provide researchers with access to their medical and pathology records, slides, tissue, and x-rays. They also will consent to a 15-minute telephone interview concerning general information about themselves and the initial manifestation of IBC and to a 30-minute interview about their medical history.

Conditions

  • Inflammatory Breast Cancer

Sponsors & Collaborators

  • United States Department of Defense

    collaborator FED

  • National Cancer Institute (NCI)

    lead NIH

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00340158 on ClinicalTrials.gov